help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Penn, R. B.
Right arrow Articles by Benovic, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penn, R. B.
Right arrow Articles by Benovic, J. L.
Am. J. Respir. Cell Mol. Biol., Volume 19, Number 2, August 1998 338-348

Mechanisms of Acute Desensitization of the beta 2AR-Adenylyl Cyclase Pathway in Human Airway Smooth Muscle

Raymond B. Penn, Reynold A. Panettieri Jr., and Jeffrey L. Benovic

Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University; and Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania


    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

beta 2-Adrenergic receptors (beta 2ARs) are important regulators of airway smooth muscle tone, and beta -sympathomimetic drugs are the most widely used agents in asthma therapy and are universally recognized as the treatment of choice for acute asthma attacks. Despite the clinical importance of beta -agonists and a good understanding of their mechanism of action in airway smooth muscle relaxation, surprisingly little is known about the manner in which the beta 2AR signaling pathway is regulated in human airway smooth muscle (HASM). In this communication, we characterize mechanisms underlying rapid desensitization of the HASM beta 2AR-adenylyl cyclase (AC) pathway. Acute homologous desensitization of beta 2AR-mediated cyclic adenosine monophosphate (cAMP) production was characterized by an ~ 60% loss of maximal responsiveness to isoproterenol (ISO) when cells were pretreated for 30 min with 1 µM ISO. Acute heterologous beta 2AR desensitization was characterized by an ~ 20% and 30% loss of maximal responsiveness to ISO challenge when cells were pretreated with forskolin and prostaglandin E2 (PGE2), respectively. Each form of desensitization was also characterized by an increase in the EC50 for ISO. beta 2AR sequestration was associated with but not required for homologous desensitization. However, sequestration was required for rapid resensitization. Minimal alterations in inherent AC activity were observed with both modes of desensitization, suggesting that the beta 2AR is the principal locus of regulation. Protein kinase inhibition by staurosporine largely reversed heterologous beta 2AR desensitization and had a small but significant effect on homologous desensitization. In contrast, bisindolylmaleimide IX, a specific PKC-inhibitor, had no effect on heterologous or homologous beta 2AR desensitization, suggesting that staurosporine effects were mediated by PKA inhibition. Overexpression of the G protein-coupled receptor kinase GRK2 in HASM cultures enhanced homologous desensitization. These data suggest that HASM beta 2ARs are highly susceptible to rapid desensitization by multiple agents, and identify both GRKs and PKA as important mediators of acute beta 2AR desensitization.


    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Inhaled beta -agonists are the most widely used agents in asthma therapy and are universally recognized as the treatment of choice for acute asthma attacks. When used in asthma treatment, beta -agonists mediate their effect primarily by activating beta 2-adrenergic receptors (beta 2ARs) on airway smooth muscle. beta 2AR activation promotes G-protein (Gs) activation of adenylyl cyclase, an increase in intracellular cyclic adenosine monophosphate (cAMP), and subsequent activation of protein kinase A (PKA). PKA activation results in a host of intracellular effects that contribute to the relaxation of airway smooth muscle. Despite the widespread use of beta -agonists and a deep understanding of their mechanism of action in airway smooth muscle relaxation, surprisingly little is known about the manner in which the beta 2AR signaling pathway is regulated in human airway smooth muscle (HASM). Alterations in beta 2AR responsiveness can be effected by mediators of inflammation, glucocorticoids, and beta -agonists themselves, in a time-dependent and cell-specific manner (1). Indeed, the issue of tachaphalaxis and the phenomenon of agonist-specific desensitization have been important considerations in beta -agonist drug design (2, 3), and may also underlie important clinical observations, such as the loss of prophylactic bronchoprotection and deterioration of asthma control (4).

Although numerous studies have identified impairment of beta 2AR-mediated functions in human and nonhuman airway smooth muscle, only a handful of studies have examined the regulation of the HASM beta 2AR-adenylyl cyclase (AC) signaling pathway per se. Mechanisms of acute (short-term) regulation of beta 2AR signaling identified in other systems have shown important roles for intracellular kinases (G protein-coupled receptor kinases [GRKs], PKA, and/or protein kinase C [PKC]) in modulating the responsiveness of this system. beta 2AR phosphorylation by PKA (induced by agents that increase intracellular cAMP levels, and associated with heterologous desensitization) and by GRK2 (specific for the agonist-occupied receptor and associated with homologous desensitization) promote rapid uncoupling of the beta 2AR from the stimulatory G protein Gs. However, the extent to which either of these desensitization mechanisms is used appears to be highly cell-specific (8), and may be related to kinase expression levels (9). In this report we characterize the salient features of the acute regulation of the beta 2AR-AC pathway in HASM cultures, and provide insight into the specific roles of GRKs and PKA in these processes. In addition, we present a technique enabling highly efficient transfection of HASM cultures, which should facilitate the further analysis of molecular mechanisms of G protein-coupled receptor-pathway regulation in HASM.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Development of HASM Cultures

HASM cultures were established as described by Panettieri and colleagues (10) from human tracheae obtained from lung transplant donors, in accordance with procedures approved by the University of Pennsylvania Committee on Studies Involving Human Beings. Briefly, a segment of trachea superior to the carina was removed under sterile conditions, and the trachealis muscle was isolated. Approximately 0.5 g (wet tissue) of trachealis muscle was isolated from the distal trachea, minced, centrifuged, and resuspended in 10 ml of buffer containing 0.2 mM CaCl2, 640 U/ml collagenase, 1 mg/ml soybean trypsin inhibitor, and 10 U/ml elastase. Enzymatic dissociation of the tissue was done for 90 min in a shaking water bath at 37°C. The cell suspension was filtered through 105-µm Nytex mesh, and the filtrate was washed with equal volumes of cold Ham's F12 medium supplemented with 10% fetal bovine serum (FBS). Aliquots of the cell suspension were plated at a density of 104 cells/cm2 in Ham's F12 medium supplemented with 10% FBS, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 2.5 µg/ml amphotericin B. The medium was replaced every 72 h. Confluent cells in flasks were passaged with 0.25% trypsin/1 mM ethylenediaminetetraacetic acid (EDTA) at a plating density of 104 cells/cm2. Cells were maintained in serum-supplemented Ham's F12 medium for 12 d after passage. The medium was changed to serum-free medium (IT medium) containing 5 µg/ml transferrin and 5 µg/ml insulin 24 h before experimentation.

HASM cultures in subculture during the second to sixth cell passages were used in the described experiments. During these cell passages, HASM cells retain native contractile protein expression, as shown by immunocytochemical staining for smooth muscle actin and myosin (11), as well as retaining functional cell-excitation coupling systems as determined by fura-2 measurements of agonist-induced changes in cytosolic calcium (11, 12). Importantly, the stability of the beta 2AR-Gs-AC signaling pathway with repeated cell passaging has been previously demonstrated (13).

Pretreatment of Cells

Cells grown to confluence on tissue-culture plates (12-well, 24-well, or 150-mm plates) were pretreated with IT medium ± vehicle (control) or the potential regulatory agent (isoproterenol [ISO], forskolin [FSK], or prostaglandin E2 [PGE2]) for 30 min. In selected experiments, staurosporine (a potent inhibitor of both PKA and PKC), bisindolylmaleimide IX (Bis IX, a potent, specific inhibitor of PKC), or concanavalin A (Con A, a lectin that blocks beta 2AR sequestration) were added to cultures 1 h (20 min for Con A) before the 30-min pretreatment period. For studies examining beta 2AR resensitization, cells were washed thrice in IT medium at 37°C and returned to the incubator for 1 h.

Following pretreatment or after recovery, cells in 12- or 24-well plates were placed on ice and washed thoroughly with cold phosphate-buffered saline (PBS), then stimulated as described subsequently. For studies assessing beta 2AR distribution in intact cells (receptor sequestration studies), cells in 150-mm dishes were harvested by incubation with 0.25% trypsin/0.53 mM EDTA (± 1 µM ISO) during the final 2 min of the pretreatment period. Cells were then washed extensively in ice-cold PBS and resuspended in PBS for subsequent binding assay (see the following discussion).

Homogenate, Membrane Preparations

Cells were scraped from tissue-culture plates into ice-cold homogenization buffer consisting of 25 mM Tris, pH 7.5; 5 mM EDTA; 1 mM ethyleneglycol-bis-(beta -aminoethyl ether)-N,N'-tetraacetic acid (EGTA); 0.02 mg/ml leupeptin; 0.2 mg/ml benzamidine; and 0.5 mM phenylmethylsulfonyl fluoride (PMSF), and were homogenized by Polytron disruption. Membranes were prepared by centrifugation of homogenates at 19,000 × g for 20 min at 4°C. Pellets were resuspended in homogenization buffer using a glass-glass dounce homogenizer, and were then washed twice by repeating the prior step of resuspension and centrifugation. The final pellet was resuspended in homogenization buffer and assayed immediately.

Whole-cell lysates used in immunoblot analysis were prepared by lysing cells in the homogenization buffer described previously containing 1% Triton X-100.

Protein concentrations from 12-well plates, cell suspensions, membrane preparations, and homogenates/lysates were determined with the Bradford assay (14).

beta 2AR-binding Assays

For preliminary determination of beta 2AR density in HASM cultures, approximately 100 µg of membrane protein were incubated in a total volume of 500 µl of 25 mM Tris, pH 7.5, plus 2 mM MgCl2, containing ~ 5 to 200 pM [125I]iodopindolol (PIN) (2,200 Ci/mmol; NEN, Boston, MA) at 37°C for 1 h. Data were transformed according to Scatchard (15) for estimation of receptor density and affinity for antagonist. In subsequent experiments, beta 2AR density in control and pretreated HASM cells was assessed by single-point (200 pM [125I]PIN) analysis as previously described (16). Nonspecific binding was determined by displacement of [125I]PIN binding with 1 µM alprenolol.

In binding studies examining beta 2AR distribution in intact cells, 100 µg of harvested cells were incubated at 14°C for 3.5 h with 200 pM [125I]PIN in the presence or absence of 1 µM alprenolol (for determination of whole-cell beta 2AR density) or 100 nM CGP 12177 (cell surface beta 2ARs), as previously described (17).

All binding reactions were terminated by addition of five aliquots each 4 ml ice-cold 25 mM Tris-HCl, pH 7.5, plus 2 mM MgCl2, and filtration through Whatman GF/C filters, using a Brandel Cell Harvester (Gaithersburg, MD).

Measurement of cAMP Production

Experiments examining cAMP accumulation were done with cells grown to confluence in 12- or 24-well plates in a modification of the method described by Kong and coworkers (18). Individual wells were stimulated at 37°C for 10 min with 500 µl PBS containing 300 µM ascorbic acid and 1 mM isobutylmethylxanthine (IBMX) (excepting time-course studies) in the absence (basal) or presence of either 10-9 to 10-4 M (-)ISO or 100 µM FSK. Preliminary studies were also done, using 1 mM RO-20-1724 (a Type IV phosphodiesterase inhibitor); experimental effects of pretreatment with agonist and kinase inhibitor were not influenced by the mode of phosphodiesterase inhibition (data not shown). Reactions were stopped by placing the plates on ice, aspirating the media, and adding 500 µl of ice-cold ethanol. After a 1-h incubation at room temperature, the ethanol from each well was transferred to an Eppendorf tube. Samples were then lyophilized for 1 h, and the pellet was resuspended in 500 µl H2O and stored at 4°C. We have determined that this method of cAMP isolation slightly improves the reproducibility of results over that with methods using acid lysis and bicarbonate neutralization. Samples were assayed for cAMP content on the following day with a radioimmunoassay using a [125I]cAMP tracer and cAMP antibody (provided by Dr. M. Ascoli, University of Iowa) as previously described (19). cAMP concentrations were determined by interpolation from a standard curve.

Transfection of HASM Cultures

HASM cells were transfected through a modification of the procedure described by Forsayeth and Garcia (20), in which a replication-deficient adenovirus (human adenovirus 5 dl343) is utilized to enhance 2-diethylaminoethanol (DEAE)-dextran-mediated transfection of cells that are typically resistant to conventional methods of transfection. For the present study we used the Ad5-guanine phosphotransferase (GPT) version of this virus (provided by P. Garcia) in which the entire E1A and E1B coding regions are replaced by a GPT coding sequence. Briefly, 4 × 106 cells were harvested and resuspended in 5 ml of Dulbecco's minimal essential medium (DMEM) containing 200 µg of DEAE-dextran, 3 × 108 plaque-forming units of Ad5-GPT, and 2 µg of each DNA to be transfected. The mixture was plated onto 10-cm tissue-culture plates and incubated for 2 h at 37°C. The medium was then removed, the cells were washed for 1 min with 2 ml of 10% dimethylsulfoxide (DMSO) in Ca2+- and Mg2+-free PBS, and the medium was replaced with serum-supplemented Ham's F12 medium. From 20 to 24 h later the transfected cells were harvested and replated at high density (2 × 104 cells/ cm2) in 12-well plates or 150-mm plates, and were grown in serum-supplemented medium. Transfection efficiency was determined from 2 to 6 d after transfection by assessment of beta -galactosidase activity (21) in cells transfected with pCMVneolacz, or by fluorescence-activated cell sorting (FACS) analysis of expression of cotransfected pcDNA3- GFPS65T.

Preparation of Plasmids for Transfection

pcDNA3beta 2AR-flag was constructed by excising the open reading frame of pBC-beta 2ARflag (provided by Dr. B. Kobilka, Stanford University) with SalI/HindIII, and the ~ 2-kb fragment was directionally cloned into pcDNA3.

pCMVneolacz was constructed by excising a 3.7-kb fragment from pAP-lacz (provided by A. Pronin, Thomas Jefferson University) with HindIII/XbaI, blunting the fragment with Klenow, and ligating the blunted fragment into pCMVneo. Correct orientation was confirmed by restriction analysis.

pcDNA3beta ARK was constructed by excising an ~ 3-kb HindIII fragment from the bovine beta ARK clone beta ARK3A (22) and ligating into the HindIII site of pcDNA3.

pcDNA3-GFPS65T, encoding a variant of Aequorea victoria green fluorescent protein (Clontech, Palo Alto, CA), was provided by L. Kallal (Thomas Jefferson University).

Immunoblotting

From 20 to 30 mg of homogenate were electrophoresed on a 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel and transferred to a nitrocellulose membrane as previously described (23). The blot was washed in 20 mM Tris, pH 7.5, plus 150 mM NaCl (Tris-buffered saline; TBS), and was blocked for 1 h in TBS plus 0.05% Tween 20 (TTBS) with 5% (wt/vol) dried nonfat milk. The blot was then incubated for several hours with the primary monoclonal antibody 3A10 (which specifically recognizes GRK2) (23), and was subsequently washed thrice for 10 min each time with TTBS. The blot was subsequently incubated for 1 h with affinity-purified goat antimouse IgG conjugated to horseradish peroxidase, in 5% milk-TTBS. The blot was then washed thrice for 10 min each in TTBS, and was visualized through the enhanced chemiluminescence (ECL) technique (Amersham, Arlington Heights, IL).

Data Analysis

Data points from individual assays represent the mean values of duplicate or triplicate measurements. Dose-response curves for ISO-mediated cAMP production were analyzed by Sigmaplot (Jandel Corp., Chicago, IL) to obtain Vmax and EC50 values. Except where indicated, cAMP generation was calculated as the increase in cAMP over basal levels and was expressed as a percentage of the values resulting from 100 µM FSK stimulation, to provide an index of beta 2AR coupling capacity (24). Statistically significant differences among groups were assessed with the t test for paired samples, with values of P < 0.05 sufficient to reject the null hypothesis. All experiments were designed such that matched control conditions existed within each experiment to enable statistical comparison of paired samples.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Characterization of beta 2AR Expression and Signaling in HASM Cultures

Preliminary studies were done to establish the levels of beta 2AR receptor density and responsiveness to beta -agonist of HASM cultures. Saturation binding analyses of [125I]PIN binding to HASM membranes from four separate cultures demonstrated high-affinity binding (Kd values ranging from 13 to 22 pM), with beta 2AR density ranging from 13 to 23 fmol/mg protein---values similar to those recently reported by Green and associates (25). beta 2AR density (fmol/ mg protein) in both intact whole-cell preparations and whole-cell homogenate preparations was approximately one-third that measured in membrane preparations from the same culture (data not shown). Figure 1 shows the time-dependent cAMP response of HASM to stimulation with 1 µM ISO, 1 µM PGE2, and 100 µM FSK, which directly activates AC (independently of beta 2AR activation). ISO elicits rapid cAMP production in a linear manner for up to 7.5 to 10 min, after which the rate of cAMP accumulation diminishes significantly, suggesting receptor desensitization. A similar profile is observed for stimulation with PGE2, although absolute cAMP production is ~ 2-fold that observed with ISO. In contrast, FSK-stimulated cAMP accumulation is more linear throughout 20 min of stimulation. Absolute values of ISO- and PGE2-stimulated cAMP production among cultures were fairly consistent, whereas values of FSK-stimulated cAMP displayed slightly greater variability. For the 15 different cultures utilized in these studies, both beta 2AR density and cAMP responses were highly reproducible with repeated cell passaging (Passages two through six were examined), as previously noted (13, 26).


View larger version (21K):
[in this window]
[in a new window]
 
Figure 1.   Time course of cAMP production in HASM cultures. Individual wells of HASM cells grown to confluence on 12-well plates were stimulated with either vehicle (basal), 1 µM ISO, 1 µM PGE2, or 100 µM FSK. cAMP was isolated and measured by radioimmunoassay as described in MATERIALS AND METHODS. Data represent mean ± SEM of four experiments.

Homologous and Heterologous Desensitization of HASM beta 2AR

We next examined acute regulation of beta 2AR responsiveness by pretreating HASM cells for 30 min with 1 µM ISO, 0.1 µM PGE2, or 10 µM FSK, and observing the cAMP response to subsequent ISO challenge (Figure 2). ISO-pretreated cells displayed a large (~ 60%) reduction in maximal ISO-stimulated cAMP production, with a ~ 3-fold increase in the EC50 value for ISO, an agonist-specific desensitization similar to that observed in the human airway epithelial cell line BEAS-2B (16). FSK- and PGE2-pretreated cells each displayed a ~ 2-fold increase in EC50 values and a significant reduction (21% and 28%, respectively) in maximal cAMP production, suggesting that acute PKA-mediated heterologous desensitization also occurs in HASM cultures. FSK-stimulated cAMP production was relatively unaffected by pretreatment with ISO, FSK, or PGE2, suggesting that desensitization is effected primarily at the beta 2AR locus under these conditions (see Figure 2 legend). Although no other studies of acute beta 2AR regulation in HASM cells exist for comparison, these results are in general agreement with those of Hall and associates (13), who demonstrated both homologous and heterologous beta 2AR desensitization following more chronic (1- to 24-h) pretreatment conditions. Thus, our data suggest that both forms of desensitization may be invoked in HASM, in contrast to our previous observations in both acutely dissociated (27) and immortalized (16) human airway epithelium, in which mechanisms of heterologous desensitization were shown to have minimal effects.


View larger version (23K):
[in this window]
[in a new window]
 
Figure 2.   Short-term beta 2AR desensitization in HASM cells. Confluent cells in 24-well plates were pretreated with vehicle (CON), 10 µM forskolin (FSK-D), 0.1 µM PGE2 (PGE-D), or 1 µM isoproterenol (ISO-D) for 30 min, washed four times with ice-cold PBS, and subsequently challenged with 10-9 to 10-4 M ISO, as described in MATERIALS AND METHODS. Data points represent increase over basal stimulation normalized to 10-4 M FSK-stimulated values (mean ± SEM of 7 to 19 experiments). Vmax values are compared with those for CON group: FSK-D: 79 ± 4% (mean ± SEM), n = 7 paired observations; PGE-D: 72 ± 3%, n = 7 paired observations; ISO-D: 41 ± 4%, n = 12 paired observations. EC50 values (nM): FSK-D: 90 ± 12 versus CON: 45 ± 6; PGE-D: 81 ± 11 versus CON: 46 ± 7; ISO-D: 157 ± 45 versus CON: 52 ± 6). Statistically significant (P < 0.05) differences were determined by paired t test for both Vmax and EC50 values for FSK-D, PGE-D, and ISO-D versus CON group. FSK-stimulated cAMP production did not differ among groups (FSK-D: 98 ± 5% of CON value; PGE-D: 102 ± 10%; ISO-D: 99 ± 5%).

Role of Sequestration in HASM beta 2AR Regulation

The homologous desensitization shown in Figure 2 was associated with significant sequestration of cell-surface beta 2ARs. Figure 3A depicts the time-dependent loss of cell surface beta 2ARs associated with acute exposure of HASM cultures to 1 µM ISO. beta 2AR density was measured in intact cells from [125I]iodopindolol binding, using either a hydrophobic or hydrophilic competitive antagonist to determine total and cell surface beta 2AR density, respectively. Cell surface beta 2AR density was calculated to be 82% of the total receptor number. A rapid loss (~ 35%) of cell surface beta 2ARs was observed within 10 min of agonist exposure, with a loss of ~ 45% observed at 30 min. Only a minor (< 10%) loss of total cell beta 2ARs was measured within the 30-min treatment period, showing that cell surface receptor loss was due to sequestration and not downregulation (the latter of which is typically associated with chronic exposure to beta -agonist). Several studies of numerous cell types (28, 29) have shown that sequestration may be blocked without affecting the initial rapid uncoupling of the receptor from AC stimulation (and thus not contributing to desensitization per se). However, these studies typically examined cell types in which beta 2ARs were expressed at high levels, in which case a significant receptor reserve might confer tolerance of cell surface receptor loss. Because HASM cells express relatively low levels of beta 2ARs, and beta 2AR signaling might therefore be affected by beta 2AR sequestration, we investigated whether blockage of beta 2AR sequestration by pretreatment with Con A influenced the pattern of homologous desensitization. As shown in Figure 3B, pretreatment with Con A had no significant effect on the dose-dependent response to ISO in either vehicle- (CON-) or ISO-pretreated cells. However, blockage of beta 2AR sequestration with Con A produced a profound effect on the ability of HASM cells to recover from homologous desensitization. Following 30 min of pretreatment with ISO, cells that were washed and allowed to incubate an additional 60 min at 37°C (Figure 3B; RECOV) showed a significantly increased Vmax value (~ 75% of CON) compared with the ISO-pretreated group. However, those cells pretreated with Con A prior to the pretreatment/recovery phases (RECOV + Con A) exhibited little if any resensitization. This finding suggests an apparent requirement of receptor recycling for rapid recovery from acute homologous desensitization, and is consistent with the finding in recent studies that implicate sequestration as important in beta 2AR dephosphorylation and resensitization (30, 31).


View larger version (20K):
[in this window]
[in a new window]
 


View larger version (26K):
[in this window]
[in a new window]
 
Figure 3.   (A) Alterations in HASM beta 2AR cellular distribution upon exposure to 1 µM ISO. HASM cells grown to confluence on 15-cm tissue-culture plates were treated with 1 µM ISO for 0 to 30 min. Cells were harvested with 2 ml 0.25 mM trypsin/1 mM EDTA ± 1 µM ISO, quenched with 10 ml ice-cold PBS containing 0.1 mg/ml soybean trypsin inhibitor, washed four times, and resuspended in ice-cold PBS. Binding studies were done with 200 pM [125I]PIN in the presence and absence of 1 µM alprenolol (for determination of whole-cell beta 2AR density), or with 100 nM CGP 12177 (cell surface beta 2AR) at 14°C for 3.5 h, as previously described (17). Data represent mean ± SD of three experiments (5-min data point is mean of two experiments). (B) Effect of Con A on homologous desensitization and resensitization of HASM beta 2AR. HASM cultures were pretreated with (+ Con A) or without 0.25 mg/ml Con A for 20 min, prior to 30-min pretreatment with ± 1 µM ISO, and beta 2AR responsiveness was subsequently assessed as described in MATERIALS AND METHODS. Selected cells were washed thrice with 37°C IT medium after ISO pretreatment, and were returned to the incubator for 1 h prior to ISO challenge (RECOV). Con A pretreatment had no significant effect on ISOD Vmax values (ISO-D: 40 ± 5% versus ISO-D + Con A: 45 ± 5%), but did have a significant effect on RECOV (RECOV: 75 ± 11% versus RECOV + Con A: 48 ± 6%; P < 0.05). Values presented are means of three paired observations; error bars are removed for graph clarity.

Role of Protein Kinases in Acute beta 2AR Desensitization

To explore the potential role of intracellular kinases in acute desensitization of the HASM beta 2AR, cells were pretreated with 1 µM staurosporine, a potent, membrane-permeable inhibitor of both PKA and PKC, for 1 h prior to 30 min pretreatment with FSK, PGE2, or ISO. As depicted by the ISO dose-response curve in Figures 4A and 4B, staurosporine pretreatment largely reversed the heterologous desensitization observed in cells pretreated with FSK (Vmax increased to 91 ± 3% from 81 ± 4% of CON value, n = 4 paired observations) and PGE2 (92 ± 6% from 73 ± 3% of CON values; n = 5 paired observations). Staurosporine also had a small but statistically significant effect on homologous desensitization (Figure 4C), increasing the Vmax of the ISO dose-response curve to 50 ± 6% from 41 ± 4% of CON values (n = 6 paired observations). Significant shifts in EC50 values were also observed in the staurosporine-pretreatment groups for each of the pretreatment conditions (FSK-D, PGE-D, or ISO-D; see Figure 4 legend).


View larger version (23K):
[in this window]
[in a new window]
 


View larger version (22K):
[in this window]
[in a new window]
 


View larger version (23K):
[in this window]
[in a new window]
 
Figure 4.   Effects of staurosporine on acute beta 2AR desensitization in HASM. HASM cells were grown to confluence in 24-well plates and pretreated with vehicle or 1 µM staurosporine (+ ST) for 60 min, followed by an additional 30 min of pretreatment with vehicle (CON), 10 µM FSK (FSK-D), 0.1 µM PGE2 (PGE-D), or 1 µM ISO (ISO-D). Cells were then washed thoroughly in ice-cold PBS and subsequently challenged with vehicle, 10-9 to 10-4 M ISO, or 100 µM FSK, as described in MATERIALS AND METHODS. Staurosporine pretreatment significantly (P < 0.05, paired t test) increased Vmax values in HASM pretreated with FSK ([A] FSK-D: 81 ± 4% [mean ± SEM] versus FSK-D + ST: 91 ± 3%; n = 4), PGE2 ([B] PGE-D: 73 ± 3% versus PGE-D + ST: 92 ± 7%; n = 5), or ISO ([C] ISO-D: 41± 4% versus ISO-D + ST: 50 ± 6%; n = 6). Staurosporine pretreatment also significantly (P < 0.05, paired t test) decreased EC50 values for ISO in each desensitization group (FSK-D: 80 ± 10 nM versus FSK-D + ST: 49 ± 6 nM; PGE-D: 75 ± 8 nM versus PGE-D ± ST: 40 ± 3 nM; ISO-D: 142 ± 52 nM versus ISO-D ± ST: 81 ± 18 nM). FSK-stimulated cAMP values did not vary among groups (data not shown).

Because staurosporine is a potent inhibitor of both PKA and PKC, we further examined the potential role of PKC in FSK-, PGE2-, and ISO-treated cells by pretreating HASM cultures with Bis IX. Pretreatment with 1 µM Bis IX had essentially no effect on either Vmax or EC50 values in control or in FSK-, PGE2, and ISO-treated cells, with dose-response curves for the four conditions being virtually superimposable (data not shown). These data suggest that the observed experimental effects of staurosporine are mediated through inhibition of PKA, and that PKC has no effect on either the heterologous beta 2AR desensitization mediated by activations of AC or on homologous desensitization in HASM.

Effect of GRK2 Overexpression on Agonist-specific beta 2AR Desensitization

In a comparison of the time course of ISO-stimulated cAMP production in multiple types of lung cells, McGraw and Liggett (9) recently demonstrated that a relatively low level of GRK2 expression in HASM is associated with an attenuated rate of short-term agonist-promoted beta 2AR desensitization. This finding suggests that GRK2 levels may be limiting in agonist-specific beta 2AR desensitization in HASM. We therefore hypothesized that increased expression of GRK2 in HASM cells would enhance agonist-specific beta 2AR desensitization.

To pursue this question it was first necessary to establish an effective technique for transient transfection of HASM cultures. Traditionally, HASM cultures have been difficult to transfect, because conventional methods (e.g., lipid-assisted or DEAE-dextran) produce extremely low levels (1%) of transfection. We therefore used a modified version of a technique recently described by Forsayeth and Garcia (20), in which DEAE-dextran is used to target unmodified plasmid DNA to the cellular endocytotic pathway while a replication-deficient adenovirus facilitates lysis of the endocytotic vesicles. Application of this method proved successful, resulting in high transfection efficiency (typically ~ 50%) as assessed either from the activity of expressed beta -galactosidase (data not shown) or from cellular fluorescence of transfected green fluorescent protein as determined by FACS (Figure 5A).


View larger version (20K):
[in this window]
[in a new window]
 


View larger version (22K):
[in this window]
[in a new window]
 
Figure 5.   Analysis of adenovirus-facilitated transient transfection of HASM. (A) FACS analysis of transfection efficiency. Populations of 4 × 106 HASM cells were transfected in 10-cm plates at Day 0, using 40 µg/ml DEAE-dextran, 7.5 × 108 pfu of Ad5-GPT, and 2 µg of pcDNA3GFPS65T (encoding Aequorea victoria green fluorescent protein) as described in MATERIALS AND METHODS. Cells were subsequently harvested on Day 3, and transfection efficiency was assessed with FACS. FACS analysis demonstrated a significant population (> 50% of total) of cells expressing GFP (right panel ) by comparison with untransfected cells (left panel) (B). beta ARK (GRK2) expression in pcDNA3vector and pcDNA3beta ARK-transfected HASM cells. Samples represent 20 µg of protein from cell lysates prepared from cells 3 and 6 d after transfection. Immunoblotting was done as described in MATERIALS AND METHODS, using the monoclonal antibody 3A10, which is specific for GRK2. Figure represents 2-s exposure of ECL blot; endogenous GRK2 expression in pcDNA3vector-transfected cells was visible with exposures of longer duration (not shown).

Transfection of HASM with pcDNA3beta ARK, encoding bovine GRK2, resulted in very high expression 3 d after transfection, with somewhat attenuated expression still observed 6 d after transfection (Figure 5B). The effect of GRK2 overexpression on agonist-specific beta 2AR desensitization was subsequently investigated in multiple experiments, using transfected cells examined 3 d after transfection (Figure 6). GRK2 overexpression resulted in a small but statistically significant increase in the loss of ISO-stimulated cAMP following ISO pretreatment. Overexpression of GRK2 in various cell types has been used to demonstrate a role for GRK2 in agonist-specific desensitization of numerous receptors, including beta 2AR (32) and beta 1AR (33). The present data support the notion advanced by McGraw and Liggett (9) that heterogeneity of GRK2 expression among cell types as well as dynamic regulation of endogenous GRK2 levels may influence desensitization patterns.


View larger version (24K):
[in this window]
[in a new window]
 
Figure 6.   Effects of GRK2 overexpression on agonist-specific desensitization. HASM were transfected with either pcDNA3vector (control) or pcDNA3beta ARK, and experiments characterizing agonist-specific desensitization were performed 3 d after transfection. Cells overexpressing GRK2 exhibited a more profound loss of beta 2AR responsiveness than did control cells (pcDNA3vector: 48 ± 4% loss, versus pcDNA3beta ARK: 62 ± 3% loss; P < 0.05, n = 8 paired observations) as a result of ISO pretreatment.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The purpose of this study was to characterize acute regulation of the beta 2AR-AC system in HASM cultures, and to elucidate mechanisms by which desensitization of beta 2ARs occurs. Thirty-minute pretreatment of HASM with either: (1) beta -agonist (inducing homologous desensitization); or (2) agents that increased intracellular cAMP independently of beta 2AR activation (inducing heterologous desensitization) resulted in a loss of beta 2AR responsiveness to subsequent ISO challenge. Minimal alterations in FSK-stimulated cAMP production were observed with both modes of desensitization, suggesting that the beta 2AR is the principal locus of regulation in HASM. Homologous desensitization was associated with but not dependent on a ~ 45% loss of cell surface beta 2ARs. However, rapid recovery of beta 2AR responsiveness from homologous desensitization was highly dependent on beta 2AR sequestration. Heterologous desensitization could be largely reversed by pretreatment of cells with staurosporine, whereas a small but significant attenuation of homologous desensitization was observed with staurosporine pretreatment. Bis IX, a potent PKC inhibitor, had no effect on beta 2AR desensitization, suggesting that the effects of staurosporine were mediated through inhibition of PKA. Overexpression of GRK2 in HASM cells enhanced ISO-mediated desensitization, implicating GRK2 as a mediator of agonist-specific desensitization whose low level of endogenous expression may limit the magnitude of desensitization in HASM cells.

Desensitization is a phenomenon in which cellular responsiveness is ultimately diminished when cells are subjected to a continuous stimulus. Desensitization of the beta 2AR-AC system characterized by diminished cAMP production has been studied in numerous expression systems and cell lines. The mechanisms involved in regulating the responsiveness of beta 2AR (and other G protein-coupled receptors) are cell-specific and complex; they include rapid alterations such as receptor phosphorylation (by PKA, GRKs, or PKC), uncoupling from G protein, and sequestration, which occur within minutes of agonist activation, as well as slower changes that may involve increased receptor degradation and decreased receptor synthesis. Although changes in receptor responsiveness may serve as the primary means of desensitization, there is also evidence that G proteins and effector enzymes such as AC may be directly regulated (for a comprehensive review of mechanisms of G protein-coupled receptor regulation, see Penn and Benovic [1]).

Despite the physiologic importance of beta 2AR stimulation in HASM function, the regulation of beta 2AR-mediated signal transduction in HASM cells remains poorly understood. Alterations in beta 2AR-AC system function may occur in vivo during airway inflammation (through PKA- or PKC-mediated mechanisms in association with heterologous desensitization) or with the repeated use of beta -agonist inhalers (agonist-specific or homologous desensitization) in asthmatic individuals. Indeed, for years, speculation about HASM beta 2AR desensitization has been a by-product of clinical studies and pulmonary function analyses of the effects of chronic beta -agonist treatment on various measures of airway responsiveness. Reports that systemic administration of beta -agonists promotes beta 2AR downregulation in peripheral blood cells, and more recent studies indicating that inhaled beta -agonists may also desensitize and/or downregulate beta 2ARs in peripheral blood (34), whole lung (35), and airway epithelium (27, 36) have further advanced this hypothesis. However, only a handful of studies have examined regulation of beta 2AR-Gs-AC cellular signaling in HASM. In an interesting study that predated the identification of many of the mechanisms involved in G protein-coupled receptor regulation, Davis and Conolly (37) noted reductions in both ISO-mediated relaxation responses and cAMP generation following 1 h pretreatment with ISO in bronchial strips obtained from carcinoma patients. In an analysis of effects of chronic beta -agonist pretreatment in HASM cultures, Hall and colleagues (13) observed a loss of AC responsiveness (cAMP generation) to subsequent ISO stimulation. Because pretreatment with FSK resulted in similar but less impressive effects, the authors concluded that mechanisms associated with both homologous and heterologous desensitization were probably involved. Green and coworkers (25) have in part confirmed the findings of Hall and colleagues in their characterization of chronic, agonist-specific desensitization and beta 2AR downregulation in HASM cultures expressing different beta 2AR polymorphisms. More recent studies by Nogami and coworkers showed that chronic exposure of HASM cultures to inflammatory mediators can both desensitize (38) and sensitize (39) beta -agonist-mediated signaling, whereas phorbol ester activation of PKC sensitizes FSK stimulation of AC (39). However, the mechanisms of both acute and chronic beta -agonist-induced beta 2AR desensitization in HASM have so far remained largely uncharacterized, with the respective contributions of intracellular kinases to these processes unknown.

The present study identifies both heterologous and homologous beta 2AR desensitization following short-term treatment of HASM cultures. HASM cultures pretreated with agents that increased intracellular cAMP either by direct activation of AC (FSK) or via a Gs-coupled receptor (PGE2) exhibited a significant loss of beta 2AR responsiveness (20% to 30% loss of Vmax and a 2-fold increase in EC50 values for ISO stimulation). These findings contrast with those previously made in our studies of BEAS-2B cells, in which pretreatment with either FSK or PGE2 elicited no change in Vmax and very small shifts in EC50 values (16). Collectively, these findings suggest that airway cells differ in their susceptibility to beta 2AR desensitization potentially elicited by local agents (e.g., inflammatory mediators) that activate AC.

A somewhat classical homologous beta 2AR desensitization was seen in HASM cultures, with a large reduction in beta 2AR responsiveness (~ 60% decrease in Vmax, ~ 3-fold increase in EC50) being observed after 30 min pretreatment with ISO. Minimal alterations in FSK-stimulated cAMP (reflecting inherent AC activity) were observed, suggesting that desensitization of the pathway occurs primarily at the level of beta 2AR-Gs coupling. Although alterations in Gs expression or function may contribute to the observed desensitization, they seem unlikely for the following reasons: First, we have not observed any discernible change in Galpha s expression as assessed by Western blotting of either whole-cell homogenates or membrane preparations derived from HASM cells treated either acutely or chronically with beta -agonist (data not shown). Second, Hall and colleagues (13) observed that pretreatment of HASM cultures with ISO did not significantly alter PGE2-mediated cAMP production, suggesting that Gs function remains unaltered in ISO-treated HASM cells. Thus, the principal locus of regulation appears to be the beta 2AR.

Acute homologous desensitization of HASM beta 2ARs was shown to be associated with a ~ 45% loss of cell surface beta 2ARs. Although the relatively low level of beta 2AR expression in HASM raises the intriguing possibility that sequestration may play a causal role in homologous desensitization in these cells, we were unable to detect any significant change in desensitization in cells pretreated with Con A. However, we were able to determine a significant effect of Con A pretreatment on the resensitization of beta 2AR signaling in HASM cultures. Cells allowed to recover for 1 h from the 30-min ISO treatment demonstrated a clear enhancement of responsiveness (to 75% from 40% of CON Vmax values), whereas recovering cells previously treated with Con A exhibited little if any recovery of responsiveness. Thus, despite extremely low levels of beta 2AR expression, HASM cells appear similar to many cell lines/ expression systems expressing high levels of beta 2AR in demonstrating no requirement for beta 2AR sequestration for acute homologous desensitization, but an apparent requirement of receptor recycling in order to facilitate rapid recovery of beta 2AR responsiveness.

The most extensively studied mechanisms of rapid beta 2AR desensitization involve receptor phosphorylation by GRKs and PKA, which serve to uncouple the receptor from Gs. However, each kinase has distinct mechanisms of activation. PKA activation can be effected by any agent that increases intracellular cAMP and may thus promote beta 2AR phosphorylation and desensitization independent of beta 2AR occupancy. beta ARK, or GRK2, the best-characterized member of a recently established family of related G protein-coupled receptor kinases (1, 40), specifically phosphorylates the agonist-occupied form of beta 2AR. Agonist activation of the beta 2AR invokes G protein beta gamma subunit-mediated translocation of GRK2 from the cytosol to the plasma membrane (41). In addition to promoting beta 2AR uncoupling, beta ARK phosphorylation of beta 2AR initiates the subsequent binding of arrestin proteins to beta 2AR (42, 43), further uncoupling the receptor and facilitating beta 2AR sequestration via clathrin-mediated endocytosis (17, 44).

Although many cells appear capable of invoking both PKA- and GRK2-mediated mechanisms of desensitization, early studies suggested that although PKA appeared to be the fundamental regulator of heterologous desensitization, its role in beta -agonist-mediated desensitization was minimal if not inconsequential. This notion stemmed from the observations that the extent of beta -agonist-mediated beta 2AR phosphorylation (45) and desensitization (45) were similar among wild-type, cyc- (which lack Gs), and kin- (which lack PKA) s49 lymphoma cells. A subsequent study by Roth and associates (50) of the kinetics of beta 2AR phosphorylation and desensitization in A431 cells concluded that GRK2-mediated phosphorylation was the most rapid and quantitatively important process contributing to rapid desensitization. However, these conclusions were not entirely supported by other studies using other cell types or expression systems with mutant beta 2ARs that lack consensus PKA or GRK2 phosphorylation sites (24, 51, 52). Using antisense oligonucleotides targeting PKA and GRK2 in multiple cell types, Shih and Malbon (8) recently reported that agonist-induced beta 2AR desensitization in Chinese hamster ovary cells and DDT1MF-2 smooth muscle cells is largely mediated by beta ARK, desensitization in rat osteosarcoma cells appears to depend predominantly on PKA activity, and PKA and beta ARK appear equally effective in A431 cells. Utilizing an alternative approach to assess beta 2AR-Gs coupling, Post and colleagues (53) recently showed that high-affinity [3H]FSK binding (an index of receptor-activated Gs-AC association) is significantly greater in kin-s49 lymphoma cells than in wild-type cells following beta -agonist pretreatment, suggesting that PKA plays an important role in the agonist-promoted uncoupling of beta 2AR.

Our data suggest that PKA is probably the principal regulator of FSK- and PGE2-mediated beta 2AR desensitization in HASM as evidenced by the ability of staurosporine (a potent inhibitor of PKA and PKC), but not Bis IX (a potent PKC-specific inhibitor), to attenuate the observed desensitization. Staurosporine (but not Bis IX) also significantly, albeit to a much lesser degree, attenuated ISO-induced beta 2AR desensitization. We can therefore attribute to PKA a small but decided role in modulating homologous beta 2AR desensitization in HASM cells. One potential explanation for an observable role of PKA in the homologous desensitization of HASM beta 2AR may be a relatively lesser capacity (compared with that in other cell types) of GRK2 to invoke agonist-mediated desensitization. McGraw and Liggett (9) have recently suggested that relatively low levels of GRK2 expression in HASM contribute to a relatively slow rate of HASM beta 2AR desensitization. In the present study, overexpression of GRK2 in HASM cultures resulted in a small but significant enhancement of ISO- induced desensitization, consistent with the hypothesis that GRK2 may be limiting in HASM cells and thus may contribute to a small degree of resistance to homologous desensitization of beta 2AR. Our results, consistent with findings in previous studies (9, 54, 55), suggest that regulation of GRK2 expression in HASM (perhaps via chronic use of beta -agonist inhalers) may modulate the degree of beta 2AR desensitization. On the other hand, the possibility also exists that other protein kinases (such as PKA or other GRKs) confer plasticity on this system and adequately compensate for a low level of GRK2 activity. To date, we have been able to identify proteins in HASM lysates immunoreactive to two separate antibodies, one specifically directed against GRK5/ GRK6, and another specifically directed against GRK6 (unpublished observations). Thus, GRK5 and/or GRK6 also may play important roles in homologous desensitization of the HASM beta 2AR. Future studies of the specificity of GRKs in HASM should help delineate further the respective roles of protein kinases in the regulation of G-protein-coupled receptors in HASM.

    Footnotes

Address correspondence to: Raymond B. Penn, Thomas Jefferson University, Kimmel Cancer Institute, Rm. 930 B.L.S.B., 233 S. 10th St., Philadelphia, PA 19107. E-mail: rpenn{at}lennon.jci.tju.edu

(Received in original form May 16, 1997 and in revised form December 3, 1997).

Dr. Benovic is the recipient of American Heart Association Established Investigator Award.
Dr. Panettieri is the recipient of Career Investigator Award from the American Lung Association.

Acknowledgments: The authors thank A. Eszterhas for his valuable contributions in establishing and maintaining HASM cultures; Drs. A. Gagnon, L. Kallal, and A. Pronin for cDNA constructs; Dr. M. Ascoli for providing cAMP antibody; and Dr. P. Garcia for providing Ad5-GPT and advice on transfection procedures.

Supported in part by grants HL58506, GM44944, HL02647, and HL55301 from the National Institutes of Health, and NASA (NRA-OLMSA).

Abbreviations AC, adenyl cyclase; beta 2AR, beta 2-adrenergic receptor; EDTA, ethylenediaminetetraacetic acid; FSK, forskolin; GRK, G-protein-coupled receptor; HASM, human airway smooth muscle; ISO, isoproterenol; PGE2, prostaglandin E2.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Penn, R. B., and J. L. Benovic. 1998 Desensitization of G protein-coupled receptors. In Handbook of Physiology, Vol. 1. P. M. Conn, editor. Oxford University Press, New York. 125-164.

2. Jack, D.. 1991. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol, and other beta-adrenoceptor agonists. Br. J. Clin. Pharmacol. 31: 501-514 [Medline].

3. Johnson, M.. 1995. Pharmacology of long-acting beta -agonists. Ann. Allergy Asthma Immunol. 75: 177-179 [Medline].

4. Cockcroft, D. W., C. P. McParland, S. A. Britto, V. A. Swystun, and B. C. Rutherford. 1993. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342: 833-837 [Medline].

5. Sears, M. R., D. R. Taylor, C. G. Print, D. C. Lake, Q. Li, E. M. Flannery, D. M. Yates, M. K. Lucas, and G. P. Herbison. 1990. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336: 1391-1396 [Medline].

6. Spitzer, W. O., S. Suissa, P. Ernst, R. I. Horwitz, B. Habbick, D. Cockroft, J.-F. Boivin, M. McNutt, A. S. Buist, and A. S. Rebuck. 1992. The use of beta -agonists and the risk of death and near-death from asthma. N. Engl. J. Med. 326: 501-506 [Abstract].

7. Vathenen, A. S., B. G. Higgins, A. J. Knox, J. R. Britton, and A. E. Tattersfield. 1988. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1: 554-558 [Medline].

8. Shih, M., and C. C. Malbon. 1994. Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta -adrenergic receptor kinase reveal distinctive cell-type specific roles in agonist-induced desensitization. Proc. Natl. Acad. Sci. USA 91: 12193-12197 [Abstract/Free Full Text].

9. McGraw, D. W., and S. B. Liggett. 1997. Heterogeneity in beta -adrenergic receptor kinase in the lung accounts for cell-specific desensitization of the beta 2-adrenergic receptor. J. Biol. Chem. 272: 7338-7344 [Abstract/Free Full Text].

10. Panettieri, R. A., R. K. Murray, L. R. DePalo, P. A. Yadvish, and M. I. Kotlikoff. 1989. A human smooth muscle cell line that retains physiological responsiveness. Am. J. Physiol. 256 (Cell. Physiol. 25):C329-C335.

11. Panettieri, R. A. 1994. Airway smooth muscle cell growth and proliferation. In Airway Smooth Muscle: Development, Regulation, and Contractility. D. Raeburn and M. A. Giembycz, editors. Birkhauser Verlag, Basel.

12. Murray, R. K., B. K. Fleischmann, and M. I. Kotlikoff. 1993. Receptor-activated Ca2+ influx in human airway smooth muscle: use of Ca2+ imaging and perforated patch-clamp techniques. Am. J. Physiol. 264 (Cell. Physiol. 33):C485-C490.

13. Hall, I. P., K. Daykin, and S. Widdop. 1993. beta 2-adrenoceptor desensitization in cultured human airway smooth muscle. Clin. Sci. 84: 151-157 [Medline].

14. Bradford, M.. 1976. A rapid and sensitive method for the quantification of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254 [Medline].

15. Scatchard, G.. 1949. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51: 660-672 .

16. Penn, R. B., S. G. Kelsen, and J. L. Benovic. 1994. Regulation of beta -agonist- and prostaglandin E2-mediated adenylyl cyclase activity in human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 11: 496-505 [Abstract].

17. Ferguson, S. S. G., W. E. I. Downey, A.-M. Colapietro, L. S. Barak, L. Menard, and M. G. Caron. 1996. Role of beta -arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271: 363-365 [Abstract].

18. Kong, G., R. Penn, and J. L. Benovic. 1994. A beta -adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor. J. Biol. Chem. 269: 13084-13087 [Abstract/Free Full Text].

19. Pereira, M. E., D. L. Segaloff, M. Ascoli, and F. Eckstein. 1987. Inhibition of choriogonadotropin-activated steroidogenesis in cultured Leydig tumor cells by the Rp diastereoisomer of adenosine 3',5'-cyclic phosphorothiate. J. Biol. Chem. 262: 6093-6100 [Abstract/Free Full Text].

20. Forsayeth, J. R., and P. B. Garcia. 1994. Adenovirus-mediated transfection of cultured cells. Biotechniques 17: 354-359 [Medline].

21. Lim, K., and C. B. Chae. 1989. A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase. Biotechniques 7: 576-579 [Medline].

22. Benovic, J. L., A. De Blasi, W. C. Stone, M. G. Caron, and R. J. Lefkowitz. 1989. beta -adrenergic receptor kinase: primary structure delineates a multigene family. Science 246: 235-240 [Abstract/Free Full Text].

23. Loudon, B., B. Perussia, and J. L. Benovic. 1996. Differentially regulated expression of the G protein-coupled receptor kinases, beta ARK and GRK6, during myelomonocytic cell development in vitro. Blood 88: 4547-4557 [Abstract/Free Full Text].

24. Lohse, M. J., J. L. Benovic, M. G. Caron, and R. J. Lefkowitz. 1990. Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J. Biol. Chem. 265: 3202-3209 [Abstract/Free Full Text].

25. Green, S. A., J. Turki, P. Bejarano, I. P. Hall, and S. B. Liggett. 1995. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13: 25-33 [Abstract].

26. Hall, I. P., and M. Kotlikoff. 1995. Use of cultured airway myocytes for study of airway smooth muscle. Am. J. Physiol. 268: L1-L11 [Abstract/Free Full Text].

27. Penn, R. B., J. R. Shaver, J. G. Zangrilli, M. Pollice, J. E. Fish, S. P. Peters, and J. L. Benovic. 1996. Effects of inflammation and acute beta-agonist inhalation on beta 2-adrenergic receptor signaling in human airways. Am. J. Physiol. 271 (Lung Cell Mol. Physiol. 15):L601-L608.

28. Homburger, V., M. Lucas, B. Cantau, J. Barabe, J. Penit, and J. Bockaert. 1980. Further evidence that desensitization of beta-adrenergic-sensitive adenylate cyclase proceeds in two steps: modification of the coupling and loss of beta-adrenergic receptors. J. Biol. Chem. 255: 10436-10444 [Free Full Text].

29. Waldo, G. L., J. K. Northup, J. P. Perkins, and T. K. Harden. 1983. Characterization of an altered membrane form of the beta -adrenergic receptor produced during agonist-induced desensitization. J. Biol. Chem. 258: 13900-13908 [Abstract/Free Full Text].

30. Yu, S. S., and R. J. Lefkowitz. 1993. beta -adrenergic receptor sequestration: a potential mechanism of receptor resensitization. J. Biol. Chem. 268: 337-341 [Abstract/Free Full Text].

31. Pippig, S., S. Andexinger, and M. J. Lohse. 1995. Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Mol. Pharmacol. 47: 666-676 [Abstract].

32. Pippig, S., S. Andexinger, K. Daniel, M. Puzicha, M. G. Caron, R. J. Lefkowitz, and M. J. Lohse. 1993. Overexpression of beta -arrestin and beta -adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptor. J. Biol. Chem. 268: 3201-3208 [Abstract/Free Full Text].

33. Freedman, N. J., S. B. Liggett, D. E. Drachman, G. Pei, M. G. Caron, and R. J. Lefkowitz. 1995. Phosphorylation and desensitization of the human beta 1-adrenergic receptor. J. Biol. Chem. 270: 17953-17961 [Abstract/Free Full Text].

34. Schuster, A., R. Kozlik, and D. Reinhardt. 1991. Influence of short- and long-term inhalation of salbutamol on lung function and beta 2-adrenoceptors of mononuclear blood cells in asthmatic children. Eur. J. Pediatr. 150: 209-213 [Medline].

35. Hayes, M., F. Qing, C. G. Rhodes, P. W. Ind, T. Jones, and J. M. B. Hughes. 1994. Effect of two weeks of salbutamol on human pulmonary beta-adrenergic receptor number and airway function. Eur. Respir. J. 7: 235s .

36. Turki, J., S. A. Green, K. B. Newman, M. A. Meyers, and S. B. Liggett. 1995. Human lung cell beta 2-adrenergic receptors desensitize in response to in vivo administered beta -agonist. Am. J. Physiol. 269(Lung Cell. Mol. Physiol. 5):L709-L714.

37. Davis, C., and M. E. Conolly. 1980. Tachyphylaxis to beta-adrenoceptor agonists in human bronchial smooth muscle: studies in vitro. Br. J. Clin. Pharmacol. 10: 417-423 [Medline].

38. Nogami, M., D. J. Romberger, S. I. Rennard, and M. L. Toews. 1994. TGF-beta 1 modulates beta -adrenergic receptor number and function in cultured human tracheal smooth muscle cells. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10):L187-L191.

39. Nogami, M., S. M. Whittle, D. J. Romberger, S. I. Rennard, and M. Toews. 1995. Lysophosphatidic acid regulation of cyclic AMP accumulation in cultured human airway smooth muscle cells. Mol. Pharmacol. 48: 766-773 [Abstract].

40. Sterne-Marr, R., and J. L. Benovic. 1995. Regulation of G protein-coupled receptors by receptor kinases and arrestins. In Vitamins and Hormones. G. Litwack, editor. Academic Press, New York. 193-234.

41. Pitcher, J. A., J. Inglese, J. B. Higgins, J. L. Arriza, P. J. Casey, C. Kim, J. L. Benovic, M. M. Kwatra, M. G. Caron, and R. J. Lefkowitz. 1992. Role of beta gamma subunits of G proteins in targeting the beta -adrenergic receptor kinase to membrane-bound receptors. Science 257: 1264-1267 [Abstract/Free Full Text].

42. Lohse, M. J., J. L. Benovic, M. G. Caron, and R. J. Lefkowitz. 1990. beta -Arrestin: a protein that regulates beta -adrenergic receptor function. Science 248: 1547-1550 [Abstract/Free Full Text].

43. Gurevich, V. V., S. B. Dion, J. J. Onorato, J. Ptasienski, C. M. Kim, R. Sterne-Marr, M. M. Hosey, and J. L. Benovic. 1995. Arrestin interactions with G protein-coupled receptors: direct binding studies of wild-type, truncated, and chimeric arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors. J. Biol. Chem. 270: 720-731 [Abstract/Free Full Text].

44. Goodman, O. B., J. G. Krupnick, F. Santini, V. V. Gurevich, R. B. Penn, A. W. Gagnon, J. H. Keen, and J. L. Benovic. 1996. Beta-arrestin acts as a clathrin adaptor protein in endocytosis of the beta-2-adrenergic receptor. Nature 383: 447-450 [Medline].

45. Strasser, R. H., D. R. Sibley, and R. J. Lefkowitz. 1986. A novel catecholamine-activated adenosine cyclic 3',5'-phosphate independent pathway for b-adrenergic receptor phosphorylation in wild-type and mutant s49 lymphoma cells: mechanism of homologous desensitization of adenylate cyclase. Biochemistry 25: 1371-1377 [Medline].

46. Green, D. A., J. Friedman, and R. B. Clark. 1981. Epinephrine desensitization of adenylate cyclase from cyc- and s49 cultured lymphoma cells. J. Cyclic Nucleotide Res. 7: 161-172 [Medline].

47. Green, D. A., and R. B. Clark. 1981. Adenylate cyclase coupling proteins are not essential for agonist-specific desensitization of lymphoma cells. J. Biol. Chem. 256: 2105-2108 [Abstract/Free Full Text].

48. Shear, M., P. A. Insel, K. L. Melmon, and P. Coffino. 1976. Agonist-specific refractoriness induced by isoproterenol: a study with mutant cells. J. Biol. Chem. 251: 7572-7576 [Abstract/Free Full Text].

49. Insel, P. A., L. C. Mahan, H. J. Motulsky, L. M. Stoolman, and A. M. Koachman. 1983. Time-dependent decreases in binding affinity of agonists for beta -adrenergic receptors of intact s49 lymphoma cells: a mechanism of desensitization. J. Biol. Chem. 258: 13597-13605 [Abstract/Free Full Text].

50. Roth, N. S., P. T. Campbell, M. G. Caron, R. J. Lefkowitz, and M. J. Lohse. 1991. Comparative rates of desensitization of beta -adrenergic receptors by the beta -adrenergic receptor kinase and the cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 88: 6201-6204 [Abstract/Free Full Text].

51. Liggett, S. B., M. Bouvier, W. P. Hausdorff, B. F. O'Dowd, M. G. Caron, and R. J. Lefkowitz. 1989. Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant beta 2-adrenergic receptors lacking phosphorylation sites. Mol. Pharmacol. 36: 641-646 [Abstract].

52. Hausdorff, W. P., M. Bouvier, B. F. O'Dowd, G. P. Irons, M. G. Caron, and R. J. Lefkowitz. 1989. Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J. Biol. Chem. 264: 12657-12665 [Abstract/Free Full Text].

53. Post, S. R., O. Aguila-Buhain, and P. Insel. 1996. A key role for protein kinase A in homologous desensitization of the beta 2-adrenergic receptor pathway in s49 lymphoma cells. J. Biol. Chem. 271: 895-900 [Abstract/Free Full Text].

54. Choi, D. J., W. J. Koch, J. J. Hunter, and H. A. Rockman. 1997. Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J. Biol. Chem. 272: 17223-17229 [Abstract/Free Full Text].

55. Ungerer, M., M. Bohm, J. S. Elce, E. Erdmann, and M. J. Lohse. 1993. Altered expression of the beta -adrenergic receptor kinase and beta 1-adrenergic receptors in failing human heart. Circulation 87: 454-463 [Abstract/Free Full Text].





This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Nino, A. Hu, J. S. Grunstein, and M. M. Grunstein
Mechanism regulating proasthmatic effects of prolonged homologous {beta}2-adrenergic receptor desensitization in airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L746 - L757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. J. Fairbank, S. C. Connolly, J. D. MacKinnon, K. Wehry, L. Deng, and G. N. Maksym
Airway smooth muscle cell tone amplifies contractile function in the presence of chronic cyclic strain
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L479 - L488.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Hu, G. Nino, J. S. Grunstein, S. Fatma, and M. M. Grunstein
Prolonged heterologous {beta}2-adrenoceptor desensitization promotes proasthmatic airway smooth muscle function via PKA/ERK1/2-mediated phosphodiesterase-4 induction
Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1055 - L1067.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wang, V. De Arcangelis, X. Gao, B. Ramani, Y.-s. Jung, and Y. Xiang
Norepinephrine- and Epinephrine-induced Distinct 2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes
J. Biol. Chem., January 25, 2008; 283(4): 1799 - 1807.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Willoughby, G. S. Baillie, M. J. Lynch, A. Ciruela, M. D. Houslay, and D. M. F. Cooper
Dynamic Regulation, Desensitization, and Cross-talk in Discrete Subcellular Microdomains during beta2-Adrenoceptor and Prostanoid Receptor cAMP Signaling
J. Biol. Chem., November 23, 2007; 282(47): 34235 - 34249.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
X. Chen, J.-C. Dai, and E. M. Greenfield
Termination of immediate-early gene expression after stimulation by parathyroid hormone or isoproterenol
Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1432 - C1440.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. M. Pascual, C. K. Billington, I. P. Hall, R. A. Panettieri Jr., J. E. Fish, S. P. Peters, and R. B. Penn
Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1425 - L1435.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. C. KIPS and R. A. PAUWELS
Long-acting Inhaled beta 2-Agonist Therapy in Asthma
Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 923 - 932.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. A. Wyatt and J. H. Sisson
Chronic ethanol downregulates PKA activation and ciliary beating in bovine bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L575 - L581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. K. Billington, R. M. Pascual, M. L. Hawkins, R. B. Penn, and I. P. Hall
Interleukin-1{beta} and Rhinovirus Sensitize Adenylyl Cyclase in Human Airway Smooth-Muscle Cells
Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 633 - 639.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. P. Krymskaya, A. J. Ammit, R. K. Hoffman, A. J. Eszterhas, and R. A. Panettieri Jr.
Activation of class IA PI3K stimulates DNA synthesis in human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L1009 - L1018.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. J. Mundell, M. E. Olah, R. A. Panettieri Jr., J. L. Benovic, and R. B. Penn
Regulation of G Protein-Coupled Receptor-Adenylyl Cyclase Responsiveness in Human Airway Smooth Muscle by Exogenous and Autocrine Adenosine
Am. J. Respir. Cell Mol. Biol., February 1, 2001; 24(2): 155 - 163.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. J. Ammit, R. K. Hoffman, Y. Amrani, A. L. Lazaar, D. W. P. Hay, T. J. Torphy, R. B. Penn, and R. A. Panettieri Jr.
Tumor Necrosis Factor-alpha -Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth-Muscle Cells . Modulation by Cyclic Adenosine Monophosphate
Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 794 - 802.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. E. MOORE, J. D. LAPORTE, J. H. ABRAHAM, I. N. SCHWARTZMAN, C. N. YANDAVA, E. S. SILVERMAN, J. M. DRAZEN, M. P. WAND, R. A. PANETTIERI Jr., and S. A. SHORE
Polymorphism of the {beta}2-Adrenergic Receptor Gene and Desensitization in Human Airway Smooth Muscle
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2117 - 2124.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
V. P. Krymskaya, M. J. Orsini, A. J. Eszterhas, K. C. Brodbeck, J. L. Benovic, R. A. Panettieri Jr., and R. B. Penn
Mechanisms of Proliferation Synergy by Receptor Tyrosine Kinase and G Protein-Coupled Receptor Activation in Human Airway Smooth Muscle
Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 546 - 554.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. K. Billington, I. P. Hall, S. J. Mundell, J.-L. Parent, R. A. Panettieri Jr., J. L. Benovic, and R. B. Penn
Inflammatory and Contractile Agents Sensitize Specific Adenylyl Cyclase Isoforms in Human Airway Smooth Muscle
Am. J. Respir. Cell Mol. Biol., November 1, 1999; 21(5): 597 - 606.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. J. Orsini, V. P. Krymskaya, A. J. Eszterhas, J. L. Benovic, R. A. Panettieri Jr., and R. B. Penn
MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation
Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L479 - L488.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Amrani, A. L. Lazaar, and R. A. Panettieri Jr.
Up-Regulation of ICAM-1 by Cytokines in Human Tracheal Smooth Muscle Cells Involves an NF-{kappa}B-Dependent Signaling Pathway That Is Only Partially Sensitive to Dexamethasone
J. Immunol., August 15, 1999; 163(4): 2128 - 2134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. P. Krymskaya, R. B. Penn, M. J. Orsini, P. H. Scott, R. J. Plevin, T. R. Walker, A. J. Eszterhas, Y. Amrani, E. R. Chilvers, and R. A. Panettieri Jr.
Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation
Am J Physiol Lung Cell Mol Physiol, July 1, 1999; 277(1): L65 - L78.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Haynes Jr., B. Obiako, P. Babal, and T. Stevens
5-(N-ethylcarboxamido)adenosine desensitizes the A2b-adenosine receptor in lung circulation
Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1877 - H1883.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. B. Penn, J.-L. Parent, A. N. Pronin, R. A. Panettieri Jr., and J. L. Benovic
Pharmacological Inhibition of Protein Kinases in Intact Cells: Antagonism of Beta Adrenergic Receptor Ligand Binding by H-89 Reveals Limitations of Usefulness
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 428 - 437.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. B. Penn, R. M. Pascual, Y.-M. Kim, S. J. Mundell, V. P. Krymskaya, R. A. Panettieri Jr., and J. L. Benovic
Arrestin Specificity for G Protein-coupled Receptors in Human Airway Smooth Muscle
J. Biol. Chem., August 24, 2001; 276(35): 32648 - 32656.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Penn, R. B.
Right arrow Articles by Benovic, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penn, R. B.
Right arrow Articles by Benovic, J. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1998 American Thoracic Society.